Aerosol Inhalation Treatment for Dyspnea

Completed · Phase 1/Phase 2

Conditions studied: Healthy, Dyspnea

In brief

The purpose of this protocol is to develop and test optimal delivery of aerosol furosemide, a treatment that has the potential to significantly improve symptom management and enhance the quality of care for patients with intractable dyspnea.

Key facts

Study ID

NCT01440764

Run by

Beth Israel Deaconess Medical Center

People needed

24

Starts

2011-09-01

Expected to finish

2017-04-01

Last updated by the study team

2017-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy

You may not qualify if…

• Unstable heart or circulation disease
• Stroke
• Seizure disorder
• Severe migraine headaches
• Liver or kidney disease
• Adrenal gland problem (Pheochromocytoma)
• Nerve problems that may affect your breathing sensation
• Brain cancer
• Drug or alcohol problem
• Systemic lupus erythematosis (SLE)
• High levels of depression, panic disorder, or other significant mental health problems
• Serious ongoing pain
• Pregnant
• Under 18 years old
• Not Fluent in English

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.